Ranmal, Sejal R. https://orcid.org/0000-0001-6972-3694
Alessandrini, Elisa https://orcid.org/0000-0003-4594-5721
Tuleu, Catherine https://orcid.org/0000-0001-8384-357X
Funding for this research was provided by:
Proveca Pharma Ltd
Article History
Received: 9 December 2025
Accepted: 22 March 2026
First Online: 2 April 2026
Declarations
:
: Sejal R. Ranmal, Elisa Alessandrini, and Catherine Tuleu have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the marketed products discussed in this article.
: The study was approved by the University College London institutional research ethics committee (study ID: 4612/037) and was performed in line with the principles of the Declaration of Helsinki. This research did not include ingestion of any substance, or assessment of drug or therapeutic efficacy. As such, it does not constitute a clinical trial, and trial registration was not applicable.
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: Not applicable.
: Conceptualization and methodology: SRR and CT; investigation and formal analysis: SRR, EA, and CT; writing (original draft and visualization): SRR; writing (review and editing): SRR, EA, and CT; funding acquisition, resources, and supervision: CT. All authors read and approved the final version and agree to be accountable for the work.